Opinion|Videos|June 17, 2024
Epidemiology and Impact of Hidradenitis Suppurativa
Author(s)Iltefat Hamzavi, MD
An expert on hidradenitis suppurativa discusses the epidemiology of the disease and its profound impact on patients’ lives.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What are some of the important epidemiological figures that are associated with hidradenitis suppurativa (HS) and how can clinicians incorporate these into their practices?
- How can this disease negatively impact patients’ lives?
Advertisement
Related to this article
Remibrutinib (Rhapsido; Novartis) is the only treatment with approved uses in both chronic spontaneous urticaria and symptomatic dermographism.
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
Multi-Hit TP53 Linked to Shorter Survival in Chronic-Phase MPN Cohorts
4
Full POLARGO Data Reveal OS, Safety for Pola-R-GemOx in DLBCL
5